Novo Nordisk Lilly Shares Slump on Price-Cut Loom Plans
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Collect feedback from your transactions and adjust categories or goals accordingly. Small, data-driven changes lead to meaningful improvements.
20,099 articlesNews of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Tariff policy volatility follows a high court ruling, and a new AI platform aims to help firms weather the disruption...
Tempus AI reported an 83% jump in Q4 revenue to $367 million but failed to hit positive full-year profitability, guid...
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
Lemonade posted first positive GAAP free cash flow in the latest quarter, a milestone that reshapes the insurtech nar...
A regional loan provider argues that trust and personal connection still drive loan success, releasing 2025 figures t...
NRMLA warns that New Jersey's proposed jersey reverse mortgage counseling rules could chill seniors from using home e...
A new study shows a widening gap between the skills-based hiring mantra and its execution, as more than half of emplo...
Near protocol climbed in a double-digit rally, buoyed by a privacy-first upgrade. Traders debate whether the move sig...
CrowdStrike delivered a record Q4 with key ARR milestones, prompting mixed but bullish reactions from four top banks....
Dive into veeva (veev) 2026 earnings with a close look at Q4 results, guidance, and what the numbers mean for investo...
In 2026, a growing number of VCs weigh founders’ families and mentors as part of the investment thesis, a trend chang...